HLFHERBALIFE LTD.Small cap · $1.36B · FY ending 2025-12-31
$13.15+1.94% · 2026-07-10 · EOD
67/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality70
wide moat · ROIC 36%Value82
P/E 6.0 · 44% of 12-mo rangeMomentum50
death · price below 200-daySmart Money68
buying · 1 funds · 1P/2S insidersMixed trendDeath cross (fresh)Below 200-day
vs S&P 500-19.4%
6-mo excess Trailing performance1M +15.7%
3M -14.0%
6M -10.7%
YTD +2.2%
1Y +26.3%
P/E vs its last 12 months (our price history): 3.5 low → 9.1 high
Current price sits at the 44th percentile of that window — mid-range. We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Wide moat — ROIC 36%
Piotroski F5/9
fundamental strength Altman ZGrey
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 17%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio0.0%
comfortable Shareholder yield0.6%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying1P / 2S insiders · 1 funds hold · 0 Congress buys
Recent insidersL'Helias Sophie · DirectorBUY$13,572
Hicks Troy · Chief Operating OfficerSELL$619,556
Lamberti Frank · Chief Commercial OfficerSELL$1.9M
Fund holders (13F)Baupost Group (Seth Klarman)$136,3052.7% of book
Chealth · 62/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.